XtalPi and CK Life Sciences partner on tumor vaccine R&D
XtalPi has entered into a strategic collaboration with CK Life Sciences, a member of the…
November 25, 2022 - 3 minutes
China
FDA gives IND approval for Ascletis Covid drug
Ascletis Pharma Inc. has revealed that the U.S. Food and Drug Administration (FDA) has approved…
November 24, 2022 - 2 minutes
Triastek cleared for 3D printed medicine treatment of ulcerative colitis
Triastek, Inc. has received clearance for its Investigational New Drug (IND) application from the United…
November 18, 2022 - 2 minutes
Ascletis announces IND approval for treatment of advanced solid tumors
Ascletis Pharma has announced the approval of the investigational new drug (IND) application by China…
November 17, 2022 - 2 minutes
VISEN growth hormone deficiency trial results announced
VISEN Pharmaceuticals has published detailed clinical data from its pivotal phase 3 study of lonapegsomatropin,…
November 17, 2022 - 2 minutes
Ascletis’ monkeypox tablet receives IND approval from the FDA
A drug to treat monkeypox from Ascletis Pharma has had its investigational new drug (IND)…
November 16, 2022 - 3 minutes
Biotheus enters agreement with Hansoh Pharma for bispecific antibody
Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for…
November 15, 2022 - 2 minutes
Nuance Pharma’s RSV vaccine cleared for trial in China
Nuance Pharma says China’s Center for Drug Evaluation (CDE) has approved its investigational new drug (IND)…
November 14, 2022 - 3 minutes
HUTCHMED announces positive gastric cancer study results in China
HUTCHMED (China) Limited has announced initial results from FRUTIGA, a phase III study of fruquintinib…
November 14, 2022 - 3 minutes
Ascentage Pharma gets Chinese approval for solid tumor study
Ascentage Pharma says its novel inhibitor of the embryonic ectoderm development (EED) protein, APG-5918, has…
November 10, 2022 - 3 minutes
Does covid vaccination boost cancer treatment?
Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against…
November 8, 2022 - 2 minutes
First patient dose completed for bladder cancer diagnostic drug
Asieris Pharmaceuticals says it has completed the first patient dose in its phase III bridging trial…
November 7, 2022 - 2 minutes
